Buy Dedana OTC / Initial Offer?

According to Tejarat News, with the beginning of 1401, the stock exchange was the initial public offering of three companies, and tomorrow the fourth company is scheduled to be the initial public offering in the capital market.

This year, Asiatek, Hoghar 1, and Ferrosil 1 companies were initially offered in the Iranian capital market, and the fourth company, Dana Pharmaceutical, enters this market.

This pharmacy will enter the OTC market tomorrow. Dedana price range is two thousand and 300 tomans to two thousand and 812 tomans. For each code, 200 real and legal quotas have been offered and the maximum required liquidity is 563 thousand Tomans. Of course, it depends on how many people participate in this initial offering.

Experts believe that given the inflation and valuation of companies, buying an initial public offering is profitable.

What company is Dedana?

Dana Pharmaceutical Company is one of the largest producers of antibiotic raw materials in the Middle East and in the last fiscal year, it has achieved sales of 2,000 billion Tomans and a net profit of 845 billion Tomans. The activities of this group include the production of pharmaceutical raw materials, the production of various drugs, the production of pharmaceutical supplies and the provision of paid production services.

This pharmaceutical company was officially registered as the 299th company in the first OTC market with a capital of 240 billion Tomans after the admission process in 1399 with the symbol “Dedana”.

Tamin Pharmaceutical Investment Companies with 43%, Shafadaro Investment with 29%, Jaber Bin Hayan Pharmaceutical with 18.5%, Osweh Pharmaceutical with 4% and Kimidaro with 3% are among the shareholders of this pharmacy.